Beneficial Effect of Flecainide Controlled Release on the Quality of Life of Patients with Atrial Fibrillation —the REFLEC-CR Study

ConclusionTreatment with flecainide CR significantly improves QoL in both paroxysmal as well as persistent AF patients, with an excellent safety profile and associated patient compliance.

Source: Cardiovascular Drugs and Therapy - March 30, 2020 Category: Cardiology Source Type: research